Free Trial

United States Antimony (UAMY) 10K Form and Latest SEC Filings 2026

United States Antimony logo
$8.60 -0.01 (-0.12%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$8.66 +0.06 (+0.70%)
As of 04:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest United States Antimony SEC Filings & Recent Activity

United States Antimony (NYSE:UAMY) has submitted 303+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in United States Antimony's financial statements. The most recent filing was a Form 3 submitted on May 15, 2026.

Form 4
UNITED STATES ANTIMONY CORP Reports Ownership Change on Apr. 2, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
United States Antimony Files Current Report on May. 15, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
United States Antimony Files Quarterly Report on May. 14, 2026

The 10-Q contains United States Antimony's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

United States Antimony SEC Filing History

Browse United States Antimony's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/15/2026 5:03 PM
United States Antimony (101538) Issuer
Winkler Shawn P (2134001) Reporting
Form 3
Initial statement of beneficial ownership of securities  
05/15/2026 3:51 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2026 8:44 AM
United States Antimony (101538) Subject
VAN ECK ASSOCIATES CORP (869178) Filed by
Form SCHEDULE 13G
05/14/2026 3:17 PM
United States Antimony (101538) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2026 8:16 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2026 7:51 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2026 3:12 PM
BlackRock, Inc. (2012383) Filed by
United States Antimony (101538) Subject
Form SCHEDULE 13G/A
04/20/2026 3:06 PM
United States Antimony (101538) Filer
Form DEF 14A
04/20/2026 3:06 PM
United States Antimony (101538) Filer
Form DEFA14A
04/10/2026 8:15 AM
United States Antimony (101538) Filer
Form PRE 14A
04/10/2026 8:15 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2026 7:46 PM
Pagen Melissa (2025257) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2026 6:43 PM
Bardswich Lloyd (1399729) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 11:16 AM
Aguirre Blaise A. (1533482) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2026 1:18 PM
Bardswich Lloyd (1399729) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 10:10 AM
EVANS GARY C (1191410) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 6:16 PM
Gustavsen John C. (1858307) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 12:50 PM
United States Antimony (101538) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/27/2026 11:19 AM
ISAAK RICHARD R (1398052) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 9:35 AM
EVANS GARY C (1191410) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2026 11:18 AM
ISAAK RICHARD R (1398052) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2026 7:33 PM
EVANS GARY C (1191410) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2026 5:33 PM
Fink Jeffrey Russell (2029601) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2026 5:37 PM
Fink Jeffrey Russell (2029601) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2026 3:36 PM
Fink Jeffrey Russell (2029601) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2026 3:37 PM
Fink Jeffrey Russell (2029601) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2026 2:50 PM
Bardswich Lloyd (1399729) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2026 12:48 PM
ISAAK RICHARD R (1398052) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/23/2026 3:39 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2026 12:47 PM
Pagen Melissa (2025257) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2026 3:00 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2026 3:00 PM
United States Antimony (101538) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/17/2026 4:11 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2026 3:22 PM
United States Antimony (101538) Filer
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
03/06/2026 8:00 AM
United States Antimony (101538) Filer
Form CERT
03/06/2026 7:09 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2026 7:11 AM
United States Antimony (101538) Filer
Form 8-A12B
02/27/2026 2:26 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2026 3:53 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2026 7:11 AM
STATE STREET CORP (93751) Filed by
STATE STREET CORP (93751) Filed by
United States Antimony (101538) Subject
Form SCHEDULE 13G
01/30/2026 1:45 PM
United States Antimony (101538) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G
I was right about SpaceX (Ad)

Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel

See how to claim your stake in SpaceX before the public can
01/29/2026 8:06 PM
Bardswich Lloyd (1399729) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2026 8:28 AM
KEANE JOHN M (1267719) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2026 8:30 AM
ISAAK RICHARD R (1398052) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2026 8:30 AM
Fink Jeffrey Russell (2029601) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2026 8:31 AM
Marinelli Jon R (2100537) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2026 3:35 PM
Aguirre Blaise A. (1533482) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2026 3:36 PM
Carrabba Joseph A (1328270) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2026 3:37 PM
MCMANUS MICHAEL A JR (1051997) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2026 7:00 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2026 6:45 PM
Marinelli Jon R (2100537) Reporting
United States Antimony (101538) Issuer
Form 3
Initial statement of beneficial ownership of securities  
01/05/2026 6:30 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2025 8:01 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2025 5:11 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2025 4:54 PM
Dugan Patrick W (1386726) Filed by
United States Antimony (101538) Subject
Form SCHEDULE 13D/A
11/07/2025 7:09 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 7:05 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2025 5:03 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2025 3:35 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2025 3:08 PM
United States Antimony (101538) Filer
Form 424B5
10/10/2025 4:28 PM
United States Antimony (101538) Filer
Form 424B5
10/10/2025 7:08 AM
United States Antimony (101538) Filer
Form S-3MEF
10/07/2025 11:47 AM
KEANE JOHN M (1267719) Reporting
United States Antimony (101538) Issuer
Form 3
Initial statement of beneficial ownership of securities  
10/07/2025 5:18 AM
United States Antimony (101538) Filer
Form 424B5
10/07/2025 5:20 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2025 8:32 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2025 5:24 AM
Bardswich Lloyd (1399729) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2025 5:45 PM
Fink Jeffrey Russell (2029601) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2025 5:32 PM
Fink Jeffrey Russell (2029601) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2025 11:48 AM
MCMANUS MICHAEL A JR (1051997) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2025 10:28 AM
ISAAK RICHARD R (1398052) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025 2:30 PM
Fink Jeffrey Russell (2029601) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025 1:38 PM
Bardswich Lloyd (1399729) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025 10:03 AM
Fink Jeffrey Russell (2029601) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2025 7:53 AM
ISAAK RICHARD R (1398052) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2025 12:35 PM
MCMANUS MICHAEL A JR (1051997) Reporting
United States Antimony (101538) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2025 6:44 PM
EVANS GARY C (1191410) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2025 3:25 PM
EVANS GARY C (1191410) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2025 7:26 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2025 5:34 PM
Bardswich Lloyd (1399729) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025 5:58 PM
ISAAK RICHARD R (1398052) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025 5:47 PM
Pagen Melissa (2025257) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025 5:53 PM
Gustavsen John C. (1858307) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2025 5:40 PM
United States Antimony (101538) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/28/2025 5:02 AM
United States Antimony (101538) Filer
Form 424B5
08/19/2025 7:34 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2025 10:26 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025 3:47 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2025 8:34 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2025 12:38 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2025 9:22 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Your book attached (Ad)

Veteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - at no charge. Inside, he reveals the one options technique that took him 11 years to find, why more strategies often lead to more losses, and the 10-minute nightly routine that replaced his 8-hour trading days.tc pixel

Grab your free copy of Simple Options Trading For Beginners today
07/17/2025 7:12 PM
BlackRock, Inc. (2012383) Filed by
United States Antimony (101538) Subject
Form SCHEDULE 13G
07/15/2025 3:51 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2025 1:15 PM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025 12:15 PM
Reed Kenneth M (1507165) Filed by
United States Antimony (101538) Subject
Form SCHEDULE 13G/A
07/01/2025 12:45 PM
United States Antimony (101538) Filer
Form 8-K/A
07/01/2025 8:56 AM
United States Antimony (101538) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2025 10:58 AM
United States Antimony (101538) Filer
Form CERT
06/30/2025 10:40 AM
United States Antimony (101538) Filer
Form 8-A12B
06/13/2025 10:51 AM
Fink Jeffrey Russell (2029601) Reporting
United States Antimony (101538) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

United States Antimony SEC Filings - Frequently Asked Questions

United States Antimony (UAMY) has submitted 303+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

United States Antimony's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on United States Antimony's financial statements page.

The most recent filing was a Form 3 submitted on May 15, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:UAMY) was last updated on 5/18/2026 by MarketBeat.com Staff.
From Our Partners